CompletedPhase 3

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

United States92 participantsStarted 2016-02

Plain-language summary

Randomized clinical trial using phenazopyridine to decrease voiding dysfunction after a retropubic midurethral sling operation.

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Planned concurrent prolapse or other procedure besides cystoscopy
✕. Using intermittent self catheterization preoperatively
✕. Undergoing spinal anesthesia for the procedure
✕. Known allergy to phenazopyridine (AKA Pyridium)
✕. Renal insufficiency
✕. Any condition or situation that in the attending physician's opinion would contra-indicate the use of phenazopyridine
✕. Subjects not competent to give consent
✕. Prisoners

Percentage of Participants With a Failed Voiding Trial

Timeframe: Postoperatively, up to 3 days after surgery

NCT IDNCT02806713

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08

Results submitted2018-09-05